Results of the nationwide survey „PolDrugs 2021”: Polish users of psychoactive substances, who are they?
, 1
Abstract
Introduction: The possibilities of the therapeutic use of illegal psychoactive substances are being researched
all over the world. Demographic and epidemiological studies are required.
The aim of the survey was to present the most important demographic data and data on the use of psychoactive
substances in Poland.
Material and methods: 2,373 responses to the original questionnaire from users from all over Poland were
collected via the Internet.
Results: People of all ages use many different psychoactive substances in many different circumstances.
The three most common agents used in Poland are marijuana, MDMA and amphetamines. 31.9% of respondents
undertook psychiatric treatment.
Conclusions: Psychiatrists rarely ask about the use of psychoactive substances. Initiation in the use of psychoactive
substances usually takes place before reaching the age of majority. Drug policy and prevention principles
need to be modified.
Keywords: drugsNPSsurvey
References
- Reiff CM, Richman EE, Nemeroff CB, et al. the Work Group on Biomarkers and Novel Treatments, a Division of the American Psychiatric Association Council of Research. Psychedelics and Psychedelic-Assisted Psychotherapy. Am J Psychiatry. 2020; 177(5): 391–410.
- https://www.ema.europa.eu/en/documents/product-information/spravato-epar-product-information_pl. (11.12.2020).
- https://www.spectrumtherapeutics. (11.12.2020).
- Król B, Szewczak B, et al. Terapeutyczne zastosowanie wybranych substancji psychoaktywnych. Psychiatria. 2019; 16(3): 154–162.
- https://news.un.org/en/story/2020/12/1079132 (11.12.2020).
- Orsolini L, Chiappini S, Corkery JM, et al. The use of new psychoactive substances (NPS) in young people and their role in mental health care: a systematic review. Expert Rev Neurother. 2019; 19(12): 1253–1264.
- Khaled SM, Hughes E, Bressington D, et al. The prevalence of novel psychoactive substances (NPS) use in non-clinical populations: a systematic review protocol. Syst Rev. 2016; 5(1): 195.
- Werley MS, Kirkpatrick DJ, Oldham MJ, et al. Toxicological assessment of a prototype e-cigaret device and three flavor formulations: a 90-day inhalation study in rats. Inhal Toxicol. 2016; 28(1): 22–38.
- Kopa PN, Pawliczak R. IQOS - a heat-not-burn (HnB) tobacco product - chemical composition and possible impact on oxidative stress and inflammatory response. A systematic review. Toxicol Mech Methods. 2020; 30(2): 81–87.
- Więckiewicz G, Smardz J, et al. Wzory stosowania syntetycznych katynonów a objawy depresyjne i parafunkcyjne zachowania ustne Psychiatr. Pol. ONLINE FIRST 2020 Feb. ; 165: 1–19.
- Internet: https://www.cinn.gov.pl/portal?id=1675807 (12.02.2021).
- https://www.emcdda.europa.eu/system/files/publications/11349/poland-cdr-2019_0.pdf (12.02.2021).
